1. Volume 68, Issue 2, Pages 196-204 (August 2015)
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model 
Gwenaelle Gravis, Jean-Marie Boher, Karim Fizazi, Florence Joly, Franck Priou, Patricia Marino, Igor Latorzeff, Remy Delva, Ivan Krakowski, Brigitte Laguerre, Jochen Walz, Fréderic Rolland, Christine Théodore, Gael Deplanque, Jean-Marc Ferrero, Damien Pouessel, Loïc Mourey, Philippe Beuzeboc, Sylvie Zanetta, Muriel Habibian, Jean-François Berdah, Jerome Dauba, Marjorie Baciuchka, Christian Platini, Claude Linassier, Jean-Luc Labourey, Jean Pascal Machiels, Claude El Kouri, Alain Ravaud, Etienne Suc, Jean- Christophe Eymard, Ali Hasbini, Guilhem Bousquet, Michel Soulie, Stéphane Oudard 
European Urology 
Volume 68, Issue 2, Pages (August 2015)
DOI: /j.eururo
Copyright © 2014 European Association of Urology Terms and Conditions

2. Fig. 1 Kaplan Meier overall survival curves by Glass risk groups.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

3. Fig. 2
Unpruned recursive partitioning tree for overall survival (OS) endpoint. HR=hazard ratio.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

4. Fig. 3
Kaplan Meier overall survival curves for the unpruned tree in (A) the learning set and (B) the validation set. Group 1: normal alkaline phosphatase (ALP), Gleason ≤8, and pain score ≤25; group 2: normal ALP, Gleason ≤8, and pain score >25; group 3: normal ALP, Gleason ≥9; group 4: abnormal ALP, Gleason score ≥8; group 5: abnormal ALP, Gleason ≤7.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

5. Fig. 4
Survival according to alkaline phosphatase (normal vs abnormal) in the whole population.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions